Contract Testing Services
Stem Cells
Liver Products
RegeneMed accelerates the development of safer, more effective drugs by providing integrated
high throughput platforms incorporating engineered human tissue-based assays. Our patented,
proprietary, core technologies enable in vitro growth of engineered human tissues, including liver,
GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical
application of these tissue-based in vitro model systems is to replace cell-based assays and
animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the
pharmaceutical industry.
RegeneMed tissue technologies are off-the-shelf
available, scalable, reproducible and specific and
designed to provide normal, diseased and
polymorphic tissues. Additional applications include
drug discovery platforms (cancer and antiviral),
biosensors (chem/biowarfare), diagnostics, medical
devices (extracorporeal devices) and tissue

RegeneMed provides 3-D human and animal liver
tissue co-cultures, industry-standard monolayer
cell-based products from the same donor for
comparison, stem cells and 3-D tissue derived from
stem cells, specialized tissue and stem cell media,
customized reagents for drug discovery, and
contract testing services for ADMET and efficacy
assessment in drug discovery.

RegeneTOX now available from human, rat, mouse,
dog, primate (other species upon request) and
engineered strains; from fresh or cryopreserved cells